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Hypoplastic left heart syndrome (HLHS) is the most frequentlyencountered of the various congenital heart malformations char-acterized by a single well-developed ventricle. The introductionmore than three decades ago by Fontan and Kreutzer of operativestrategies to separate the systemic and pulmonary circulations inpatients with tricuspid atresia led to the recognition that all
single-ventricle anomalies could be managed in a similar fashion, at least in theory.
The unique challenge of aortic atresia–HLHS was that the presence of systemic
outflow obstruction and thus ductal dependency of the systemic circulation resulted
in rapid and predictable hemodynamic deterioration of neonates with this condition
and demanded an operative strategy considerably more ambitious than merely
regulating pulmonary blood flow by means of either a pulmonary artery band or a
systemic-pulmonary shunt. The availability in the 1970s of prostaglandins to ensure
patency of the ductus arteriosus was of major importance in the overall management
of neonates with HLHS.
During the same era, numerous investigators and surgical teams experimented
with a host of innovative and imaginative strategies to stabilize the circulation of
neonates with aortic atresia and related malformations. In addition to the magnitude
of the overall challenge, two things became apparent: (1) separation of the systemic
and pulmonary circulations by atriopulmonary or cavopulmonary connection could
not be achieved successfully in young infants because of the prohibitively high
pulmonary vascular resistance and (2) palliative operative strategies that did not
preserve the architecture and integrity of the pulmonary arteries and their distal
vascular bed only postponed by months the inevitable death that previously had
typically occurred during the first few weeks of life.
From these early lessons, Norwood distilled the essential features of successful
neonatal palliation of aortic atresia and other forms of HLHS: (1) association of the
aorta directly with the right ventricle in a fashion that guarantees unobstructed flow
from the right ventricle to the systemic circulation and growth potential for the aorta,
obviating the need for further aortic surgery; (2) regulation of pulmonary blood flow
to ensure proper growth and development and maturation of the pulmonary vascu-
lature, to avoid the development of pulmonary vascular obstructive disease, and to
minimize the volume load on the ventricle; and (3) establishment of a large
interatrial communication to avoid pulmonary venous hypertension. Thus, in 1983
Norwood and his associates1 described successful physiologic repair of aortic
atresia–HLHS by means of an initial palliation based on these principles, followed
by a modified Fontan procedure.
Physiologic repair of HLHS has evolved from a 2-staged operative strategy,
which 10 to 15 years ago was performed in a handful of centers in this country, to
a 3-staged operative strategy that is now performed at most major pediatric cardiac
surgery centers, not only in the United States but in most parts of the world. The
immense value of interposing a second-stage procedure, a hemi-Fontan or bidirec-
tional superior cavopulmonary anastomosis, rapidly became apparent. Limiting the
duration of the fragile palliated state to a few months, combined with early reduction
of the volume load of the single ventricle, has enabled many more children to
eventually undergo successful total cavopulmonary connection. Some unresolved
issues remain regarding the optimal timing and exact technical features of the
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eventual total cavopulmonary connection. Nonetheless, it is
the initial palliative stage of surgical reconstruction, and the
ensuing months characterized by parallel systemic and pul-
monary circulations, that still pose the greatest challenges in
the overall management scheme.
In this issue of the Journal, Poirier and associates2 sum-
marize the excellent results of their surgical efforts with a
challenging group of neonates and infants with HLHS
(80%) and other lesions with ductal dependency of systemic
blood flow (20%). As their methods produced an operative
survival of 83%, those methods merit careful study. The
principal modification of the stage I Norwood procedure
that Dr Mee and his surgical team at the Cleveland Clinic
espouse is the use of only autologous tissue to reconstruct
the aortic arch. This differs from what the authors describe
as the “standard Norwood operation,” which includes the
use of homograft vascular tissue to augment the amalgam-
ation of the native ascending aorta, the arch, and the prox-
imal main pulmonary trunk. In fact, the procedure described
in 1983 by Norwood’s group used only autologous tissue to
accomplish this amalgamation.
Over the ensuing 17 years, a variety of materials have
been incorporated into the reconstruction, with homograft
vascular tissue proving to be the best choice on the basis of
availability, handling characteristics, and hemostatic prop-
erties. Different surgeons may invoke different rationales
for the use of vascular patch material in the stage I pallia-
tion. However, more than anything else its use as described
by Norwood allows for a standardized operative approach to
the neonate with single-ventricle physiology and systemic
ventricular outflow obstruction, regardless of specific ana-
tomic details and regardless of the degree of hypoplasia of
the ascending aorta and the various elements of the arch. As
a result, many of Norwood’s pupils and prote´ge´s have come
to refer to the stage I palliative procedure as the “omni”
procedure, because of its universal applicability. In this
operation, the native aorta is incised along its lesser curva-
ture from a point well distal to ductal entry into the thoracic
aorta, along the lesser curve of the aortic arch, and down the
medial aspect of the diminutive ascending aorta to a point
directly opposite the transected pulmonary trunk. The entire
arch is augmented with a shield-shaped gusset of cryopre-
served pulmonary artery homograft tissue. Proximally, the
ascending aorta is anastomosed in side-to-side fashion to the
proximal pulmonary trunk, and the amalgamation is com-
pleted by suturing the homograft gusset to the remainder of
the circumference of the pulmonary trunk. The anastomosis
of the ascending aorta to the pulmonary trunk is technically
the most critical part. When performed correctly, it leaves a
very short segment of native ascending aorta to serve as the
immediate pre–coronary arterial pathway. Repeated expe-
rience with fashioning the homograft gusset results in an
aortic reconstruction that, while larger than normal proxi-
mally, looks very much like “an aortic arch.”
As Norwood did originally, Mee and his associates have
chosen to perform the entire reconstruction with autologous
tissue. They infer that this might optimize aortic growth and
avoid degeneration of patch material. Thus, their modifica-
tion of the Norwood procedure consists of restructuring the
arch by means of a combined anastomosis of the proximal
main pulmonary artery to the arch and descending aorta
without the use of foreign material. In this regard, it is
fundamentally similar to the procedure described in 1995 by
Fraser and Mee3 and in the same year by Brawn and
associates4 of Birmingham, United Kingdom. Both groups
have achieved noteworthy results with respect to early sur-
vival, and the 83% hospital survival in the present report
compares very favorably with most contemporary results.
However, a careful analysis of the results presented by
Poirier and coworkers2 suggests that this operative method
may be less suitable for patients with the tiny ascending
aorta that is the hallmark of aortic atresia, the most extreme
and most common anatomic subset of HLHS.
The number of patients in this report with a truly dimin-
utive ascending aorta (less than 2.5 mm) corresponds very
closely to the number with aortic atresia. They make up a bit
more than one half of the total number of patients with
HLHS, and the rates of early and intermediate mortality for
this group are 33% and 50%, respectively. In recent cases,
the authors appropriately addressed the challenge of ensur-
ing adequate coronary blood flow through a series of three
modifications to the operative technique and expressed op-
timism with respect to the procedure that has most recently
evolved. Yet early and intermediate mortality are not sig-
nificantly lower in the latter half of the series than in the first
half. By way of contrast, aortic atresia and small size of the
ascending aorta have not been identified as risk factors for
mortality in series from Philadelphia5 and Ann Arbor,6
wherein the technical features of stage I palliation included
lengthwise incision into the ascending aorta and patch aug-
mentation of the aortic reconstruction. Other series with
other operative techniques have identified aortic atresia and
small aortic size as risk factors for mortality and have been
correlated with autopsy findings of myocardial ischemia and
pre-coronary stenosis.7,8
The palliated state of patients with HLHS is a period of
significant vulnerability. This is certainly in large part a
consequence of the abnormal physiology of coronary blood
flow in this state. There is considerable diastolic runoff into
the systemic–pulmonary artery shunt. Fogel and associates9
used echocardiography and Doppler flow studies to assess
coronary blood flow in patients with aortic atresia. After
stage I palliation, coronary blood flow was predominantly
during systole, as compared with the predominance of dia-
stolic coronary blood flow in normal hearts. In addition,
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coronary blood flow requirements in the palliated state
considerably exceed normal levels until the second-stage
procedure, when the volume load on the single ventricle is
reduced. Thus, the merit of technical modifications to the
Norwood stage I palliative procedure must be considered
with respect to their influence on coronary blood flow and
its impact on survival, not only at the time of initial palli-
ation, but throughout the several months of life that precede
the second-stage procedure.
Intuitively, it is attractive to assume that the elimination
of patch material in an aortic reconstruction may be asso-
ciated with a lower incidence of late aortic arch obstruction.
Nonviable patch material, even homograft tissue, is not
expected to grow. Curiously, nearly all aortic arch obstruc-
tion after initial palliation of HLHS is encountered in the
first several months of life.10 This is almost certainly related
to the technical adequacy of the reconstruction rather than
non-growth of the augmented aorta. Growth characteristics
of the reconstructed aortic arch after surgical treatment of
HLHS have been studied by Mahle and colleagues11 in
patients operated on a decade ago by Dr Norwood. These
echocardiographic studies demonstrate that growth of the
reconstructed aorta parallels growth seen in normal sub-
jects. Postmortem investigations in Mahle’s study reveal
that all of the growth of the reconstructed aorta occurs in the
native tissue that makes up at least a portion of the circum-
ference of the aorta at every level. In angiographic studies
done on patients 4 to 10 years after initial palliation, the
aortic arch looks like an aortic arch, although larger than
normal proximally. At present, one can only speculate that
similarly satisfactory results will eventually be observed in
patients whose aortic reconstruction uses only autologous
tissue.
Although it is essential that we continue to refine the
strategies of operative management of HLHS, at the heart of
this issue is the question of whether Norwood’s stage I
palliative operation should be altered in ways that may
introduce new variables with respect to coronary perfusion,
particularly in patients with aortic atresia and a truly dimin-
utive ascending aorta. It is conceivable that the most recent
modifications of aortic configuration described by Poirier
and associates2 may eliminate the problems with coronary
insufficiency that were encountered early in the series. It is
important that technical advances continue to be made both
with respect to preoperative, intraoperative, and postopera-
tive management of the abnormal physiologic state of these
patients and with respect to the surgical exercises them-
selves. In the latter area, modifications such as those pro-
posed by Poirier and coworkers2 have among their objec-
tives the goal of reducing the potential effects of
cardiopulmonary bypass and circulatory arrest. Further
progress in these areas is expected to contribute to the
optimization not only of survival, but also of functional and
neurologic outcomes. Growth of the surgically created path-
ways remains a consideration and will be the subject of
ongoing investigations. The lessons learned in the surgical
management of HLHS not only have dramatically affected
the lives of children with this common heart malformation,
but also have contributed immensely to the successful man-
agement of the entire spectrum of critical heart malforma-
tions necessitating surgical intervention early in life.
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